US Democrats are still trying to pass a bill that would cap diabetes patients’ out-of-pocket insulin expenses in the country.
Should it pass, the legislation could impact insulin makers supplying the US, including Novo Nordisk, Eli Lilly, and Sanofi, which are behind 90% of insulin sales in the US.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Genmab to submit cancer candidate epcoritamab to the FDA before year-end
The US Food and Drug Administration will receive a marketing authorization application from Genmab and partner Abbvie in the second half of this year.
Novo Nordisk denied general conditional reimbursement for Wegovy in Denmark – again
The Danish Medicines Agency has been told for the second time that the price of the obesity drug is not in line with the effect it provides.
Bavarian Nordic is working with EMA on monkeypox vaccine label expansion
Bavarian Nordic’s smallpox vaccine Imvanex has previously been used off-label to protect close contacts from monkeypox in several countries. The Danish vaccine firm is now working with the EMA to expand the label in an ”accelerated process.”
Coloplast's climate goals approved by international initiative
The Science Based Targets initiative has approved Coloplast’s carbon emission reduction goals.
Top news from MedWatch this week
Miss anything?
Scientific Writer 
Regulatory Affairs Manager - Maternity Cover 
Global Learning Specialist 
Director Regulatory Affairs 
Senior Toxicologist 
Device Associate Director/Senior Project Leader 
Specialist within CMC, Regulatory Affairs Life Cycle Management 
KLIFO is looking for a Project Director for our office in Denmark or Germany or Sweden 
Chair of the Board 
Senior Manager/Associate Director, Global Regulatory Affairs, CMC 
Principal Scientist – Pharmacology 
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients